Phase 1 Liver Cancer Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Liver CancerPancreatic CancerGastric Cancer+6 more
Arbele Pty Ltd68 enrolled3 locationsNCT05411133
Recruiting
Phase 1
Brodalumab in the Treatment of Immune-Related Adverse Events
Breast CancerLiver CancerEsophageal Cancer+15 more
Brian Henick, MD11 enrolled1 locationNCT06673329
Recruiting
Phase 1Phase 2
Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Liver CancerLung Cancer
Second Affiliated Hospital of Guangzhou Medical University100 enrolled1 locationNCT05187338
Recruiting
Phase 1
Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors
Breast CancerLiver CancerLung Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University40 enrolled1 locationNCT04842812
Recruiting
Phase 1
GPC3/Mesothelin-CAR-γδT Cells Against Cancers
Liver CancerLung CancerPancreas Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled1 locationNCT06196294